Stock Scorecard
Stock Summary for Aethlon Medical Inc (AEMD) - $1.84 as of 9/1/2026 4:38:16 PM EST
Total Score
14 out of 30
Safety Score
33 out of 100
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for AEMD
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for AEMD
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for AEMD
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for AEMD
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for AEMD (33 out of 100)
| Stock Price Rating (Max of 10) | 2 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 5 |
| Book Value to Price (Max of 10) | 10 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 5 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for AEMD
Financial Details for AEMD
Company Overview |
|
|---|---|
| Ticker | AEMD |
| Company Name | Aethlon Medical Inc |
| Country | USA |
| Description | Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life- and organ-threatening diseases in the United States. The company is headquartered in San Diego, California. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL DEVICES |
| Most Recent Quarter | 6/30/2026 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 1.84 |
| Price 4 Years Ago | 1,101.60 |
| Last Day Price Updated | 9/1/2026 4:38:16 PM EST |
| Last Day Volume | 279,445 |
| Average Daily Volume | 2,193,419 |
| 52-Week High | 79.00 |
| 52-Week Low | 1.92 |
| Last Price to 52 Week Low | 4.17% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 25.53 |
| Sector PE | 44.74 |
| 5-Year Average PE | -2.05 |
| Free Cash Flow Ratio | 0.27 |
| Industry Free Cash Flow Ratio | 73.52 |
| Sector Free Cash Flow Ratio | 35.74 |
| Current Ratio Most Recent Quarter | 5.42 |
| Total Cash Per Share | 6.94 |
| Book Value Per Share Most Recent Quarter | 10.89 |
| Price to Book Ratio | 0.30 |
| Industry Price to Book Ratio | 2.97 |
| Sector Price to Book Ratio | 8.85 |
| Price to Sales Ratio Twelve Trailing Months | 2.37 |
| Industry Price to Sales Ratio Twelve Trailing Months | 37.34 |
| Sector Price to Sales Ratio Twelve Trailing Months | 40.40 |
| Analyst Buy Ratings | 0 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 711,140 |
| Market Capitalization | 1,308,498 |
| Institutional Ownership | 9.79% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 46.58% |
| Reported EPS 12 Trailing Months | -14.65 |
| Reported EPS Past Year | -4.02 |
| Reported EPS Prior Year | -15.89 |
| Net Income Twelve Trailing Months | -6,937,522 |
| Net Income Past Year | -7,151,469 |
| Net Income Prior Year | -13,388,089 |
| Quarterly Revenue Growth YOY | 4,278.00% |
| 5-Year Revenue Growth | -100.00% |
| Operating Margin Twelve Trailing Months | 0.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 4,933,579 |
| Total Cash Past Year | 5,026,458 |
| Total Cash Prior Year | 5,501,261 |
| Net Cash Position Most Recent Quarter | 4,933,579 |
| Net Cash Position Past Year | 4,979,732 |
| Long Term Debt Past Year | 46,726 |
| Long Term Debt Prior Year | 46,726 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 0.99 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 4,886,272 |
| Total Stockholder Equity Prior Year | 5,123,530 |
| Total Stockholder Equity Most Recent Quarter | 5,199,329 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -1,910,976,162 |
| Free Cash Flow Per Share Twelve Trailing Months | -2,687.20 |
| Free Cash Flow Past Year | -7,002,096,000,000 |
| Free Cash Flow Prior Year | -7,645,534 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | False |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.40 |
| MACD Signal | -0.40 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 1.44 |
| RSI | 0.00 |
| 50-Day SMA | 216.47 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 538.99 |
System |
|
| Modified | 9/1/2026 4:38:18 PM EST |